Evidence map›Paper›PMID 38707787›Full record

ReviewExploratory research in clinical and social pharmacy2024

European community pharmacists practice in tackling influenza.

Marleen Haems, Mauro Lanzilotto, Andrea Mandelli, Hélder Mota-Filipe, Ema Paulino, Beata Plewka, Olivier Rozaire, Jens Zeiger

Abstract readReview
In one paragraph

Review in Exploratory research in clinical and social pharmacy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Disparities in Seasonal Influenza Vaccination in Europe.Immunity, inflammation and disease · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marleen HaemsKoninklijk Oost-Vlaams Apothekersgild (KOVAG, Royal Society of Pharmacists of East Flanders), Brouwerijstraat 1, 9031 Ghent, Belgium.
Mauro LanzilottoFederazione Nazionale dei Titolari di Farmacia Italiani (Federfarma, National Federation of the Italian Pharmacy Owner), Via Emanuele Filiberto 190, 00185 Rome, Italy.
Andrea MandelliFederazione degli Ordini dei Farmacisti Italiani (FOFI, Federation of the Orders of Italian Pharmacists), Via Palestro 75, 00185 Rome, Italy.
Hélder Mota-FilipeFaculty of Pharmacy of the Universidade de Lisboa (FFUL), Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal.
Ema PaulinoAssociação Nacional das Farmácias (ANF, National Association of Pharmacies), Rua Marechal Saldanha 1, 1249-069 Lisbon, Portugal.
Beata PlewkaPharmacy Practice Division, Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, 6 Grunwaldzka Street, 60-780 Poznan, Poland.
Olivier RozaireUnion Régionale des Professionnels de Santé Pharmaciens Auvergne Rhône Alpes (URPS AuRA, Regional Union of the Healthcare Professionals, Pharmacists, Auvergne Rhône Alpes), rue Garibaldi 194B, 69003 Lyon, France.
Jens ZeigerMarketing Verein Deutscher Apotheker (MVDA, Marketing Association of German Pharmacists), Emil-Hoffmann-Straße 1a, 50996 Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In many European countries, flu vaccination coverage rates are below the 75% target. During the COVID-19 pandemic, many pharmacists around Europe were involved as vaccine administrators and demonstrated positive results in improving vaccine uptake. This paper explores the challenges, accomplishments, and best practices of various European pharmacists' associations in administering vaccines and positively contributing to public health. Methods: Eight pharmacists representing various associations from different countries across Europe (Italy, Belgium, Poland, Portugal, France, and Germany) convened to discuss their role as vaccination providers, the advantages, and strategies for improvement, and to identify barriers and gaps in the vaccination administration process, especially focusing on the administration of seasonal flu vaccines. Results: Currently, 15 European countries allow community pharmacists to dispense and administer flu vaccines. Among the ones that attended the meeting, Portugal initiated the flu immunization program at the pharmacy earliest, before the COVID era, but in other countries, the process started only in the last couple of years. Initial hesitancy and reluctance by other HCPs or institutions were overcome as the pilot projects showed positive and cost-effective public health results. Today, pharmacists are considered crucial professional figures to provide immunization services against COVID-19, the flu, and other vaccine-preventable diseases, and pursue important public health goals.Key takeaways to enhance the pharmacist's role in providing immunization services against vaccine-preventable diseases include improving interaction with policymakers and the public, generating real-world evidence highlighting public health benefits, and ensuring ongoing professional education and training for pharmacists. Conclusion: Vaccinating pharmacists are gaining recognition of their role and the benefits derived from their broader involvement in the healthcare system, including immunization programs. Further efforts are needed in each country for an adequate recognition of the profession and a broader utilization of pharmacy services to exploit the benefit of immunization, especially against the flu.

Indexed as

COVID-19InfluenzaPharmacistPharmacyPublic healthVaccination

Identifiers

PMID38707787
PMCPMC11068921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.